Navigation Links
Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
Date:6/12/2008

BETHESDA, Md., June 12 /Xinhua-PRNewswire/ -- Chindex International, Inc. (Nasdaq: CHDX), an independent American provider of international healthcare services and Western healthcare products in the People's Republic of China, today announced results for its fiscal year end and fourth quarter ended March 31, 2008.

For the 2008 fiscal year, the Company reported total revenue of $130.1 million, an increase of 23% over the prior year, and income from continuing operations increased 80% to $8.3 million from $4.6 million in the prior year. Net income increased 34% to $3.7 million, or earnings per share of $0.32 compared to net income of $2.7 million or earnings per share of $0.29 for the year ended March 31, 2007.

For the quarter ended March 31, 2008, revenue was $34.6 million, an increase of 40% over the prior year, and income from continuing operations decreased 55% to $426,000 from $939,000 in the prior year. The net loss for the quarter ended March 31, 2008 was $2.7 million or loss per share of $0.20 compared to net income of $665,000, or earnings per share of $0.06, for the quarter ended March 31, 2007. The quarterly results were negatively impacted by certain non-routine year-end adjustments as well as the interest charge related to the conversion of a JP Morgan convertible bond.

The Company's balance sheet as of March 31, 2008 shows cash, cash equivalents and restricted cash of $80.4 million, total assets of $136.0 million, a current ratio of 4.51:1 and stockholders' equity of $87.4 million.

Roberta Lipson, President and CEO of Chindex, commented on the results: "We continue to see great opportunity for our healthcare businesses in China -- the world's fastest growing market. Our revenue growth and profitable $10,342,000 $(2,607,000) $7,735,000

Foreign exchange gain 604,000

Income from continuing operations $8,339,000

Other (expense), net (2,642,000)

Income from continuing operations

before income taxes $5,697,000

Healthcare Medical

Services Products Total

As of March 31, 2007:

Assets $34,129,000 $28,778,000 $62,907,000

For the twelve months ended March

31, 2007:

Sales and service revenue $47,944,000 $57,977,000 $105,921,000

Gross Profit n/a* 14,086,000 n/a*

Gross Profit % n/a* 24% n/a*

Income (loss) from continuing

operations before foreign

exchange $5,028,000 $(1,154,000) $3,874,000

Foreign exchange gain 771,000

Income from continuing operations $4,645,000

Other (expense), net (458,000)

Income from continuing operations

before income taxes $4,187,000

* Gross profit margins are not routinely calculated in the healthcare

industry.

For more information, please contact:

Lawrence Pemble or Judy Zakreski

Chindex International, Inc.

Tel: +1-301-215-7777

operating results for fiscal year 2008 are a window on the great potential we see as we set the stage for the next chapters of growth in both our divisions.

"Revenue from the Healthcare Services division for the year was $65.8 million, an increase of 37% over the prior year with income from continuing operations of $10.3 million, compared with income from continuing operations of $5.0 million in the previous year. This improvement of over 106% reflects increasing profitability in both the Beijing and Shanghai markets. The Healthcare Services division operates the Company's United Family Healthcare (UFH) network of private hospitals and clinics in China. Chindex operates the only foreign-invested, multi-facility hospital network in China.

"The continued rapid growth on both top and bottom lines on a comparable basis versus last year in our United Family Healthcare network speaks to the growing potential of the market as well as our increased service offerings in both markets. We celebrated the 10th anniversary of our hospital operations in Beijing and expect the growth to continue even as we are planning the next phases of geographic and facility expansion

"Our near term expansion plans for the United Family Healthcare network include a new outpatient center in Shanghai as well as strategic geographic expansion into the Guangzhou market, first with an outpatient center closely followed by the development of a major general hospital facility. The two outpatient centers are scheduled to open this summer. The new hospital in Guangzhou and a second facility for Beijing are now under design and development.

"The Medical Products division markets, distributes and sells select medical capital equipment, instrumentation and other medical products for use in hospitals in mainland China and Hong Kong."

"Revenue for the division during the year was $64.2 million, an 11% increase from the prior year with a loss from continuing operations of $2.6 million compared with a loss from continuing operations of $1.2 million in the prior year. The increase in revenue was primarily attributable to successfully increasing market share in ultrasound product sales. This positive factor was somewhat offset by the impact of ongoing and unfinished reforms by the government of the procurement process in the Chinese healthcare system, which included increased requirements for public tendering, as well as -- and perhaps most importantly -- delays in the product registration for market entry for certain of our products.

"Some of the market issues impacting our 2008 period in the products division began to see resolution by year end. While we did not meet our performance targets in the division, during the year we did see significant progress in market penetration for our range of ultrasound products, as well as, the successful installations of additional daVinci surgical robot systems in Hong Kong and the resumption of our government backed loan financing programs based on U.S. Export-Import Bank guarantees. We expect improved performance and a return to profitability in the division in 2009," said Lipson.

Lipson concluded, "Our two divisions operate in very synergistic market segments, Healthcare Services and Medical Products. We are confident in the opportunity in China in the Healthcare space and we are uniquely positioned with 'first to market advantage' in these areas."

About Chindex International, Inc.

Chindex is an American healthcare company that provides healthcare services and supplies medical capital equipment, instrumentation and products to the Chinese marketplace, including Hong Kong. It provides healthcare services through the operations of its United Family Hospitals and Clinics, a network of private primary care hospitals and affiliated ambulatory clinics in China. The Company's hospital network currently operates in the Beijing and Shanghai metropolitan areas. The Company sells medical products manufactured by various major multinational companies, including Siemens AG and Intuitive Surgical, which are the Company's exclusive distribution partners for the sale and servicing of color doppler ultrasound systems and surgical robotic systems respectively. It also arranges financing packages for the supply of medical products to hospitals in China utilizing the export loan and loan guarantee programs of both the U.S. Export-Import Bank and the German KfW Development Bank. With twenty-five years of experience, approximately 1,200 employees, and operations in China, Hong Kong, the United States and Germany, the Company's strategy is to expand its cross-cultural reach by providing leading edge healthcare technologies, quality products and services to Greater China's professional communities. Further company information may be found at the Company's websites, http://www.chindex.com and http://www.unitedfamilyhospitals.com .

Statements made in this press release relating to plans, strategies, objectives, economic performance and trends and other statements that are not descriptions of historical facts may be forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking information is inherently subject to risks and uncertainties, and actual results could differ materially from those currently anticipated due to a number of factors, which include, but are not limited to, the factors set forth under the heading "Risk Factors" in our annual report on Form 10-K for the year ended March 31, 2007, updates and additions to those "Risk Factors" in our interim reports on Form 10-Q, Forms 8-K and in other documents filed by us with the Securities and Exchange Commission from time to time. Forward-looking statements may be identified by terms such as "may", "will", "should", "could", "expects", "plans", "intends", "anticipates", "believes", "estimates", "predicts", "forecasts", "potential", or "continue" or similar terms or the negative of these terms. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. We have no obligation to update these forward- looking statements.

Financial Summary Attached

CONSOLIDATED CONDENSED STATEMENTS OF OPERATIONS

(thousands except share and per share data)

Three months ended Year ended

March 31, March 31,

2008 2007 2008 2007

Product sales $17,162 $11,861 $64,241 $57,977

Healthcare services revenue 17,462 12,821 65,817 47,944

Total revenue 34,624 24,682 130,058 105,921

Cost and expenses

Product sales costs 13,266 8,942 47,679 43,891

Healthcare services costs 14,113 10,514 51,810 40,534

Selling and marketing

expenses 3,556 2,725 12,175 9,930

General and administrative

expenses 3,263 1,562 10,055 6,921

Income from continuing

operations 426 939 8,339 4,645

Other (expenses) and income

Interest expense (3,002) (195) (3,575) (766)

Interest income 659 51 1,159 238

Miscellaneous (expense)

income - net (55) 72 (226) 70

(Loss) income from continuing

operations before income

taxes (1,972) 867 5,697 4,187

Provision for income taxes (714) (219) (2,042) (1,205)

Net (loss) income from

continuing operations (2,686) 648 3,655 2,982

Income (loss) from

discontinued operations 0 17 (0) (247)

Net (loss) income $(2,686) $665 $3,655 $2,735

Net (loss) income per common

share - basic

Continuing operations $(.20) $.06 $.32 $.29

Discontinued operations (.00) (.00) (.00) (.02)

Net (loss) income $(.20) $.06 $.32 $.27

Weighted average shares

outstanding - basic 13,432,561 10,608,003 11,369,607 10,286,870

Net (loss) income per

common share - diluted

Continuing operations $(.20) $.05 $.27 $.26

Discontinued operations (.00) (.00) (.00) (.02)

Net (loss) income $(.20) $.05 $.27 $.24

Weighted average shares

outstanding - diluted 13,432,561 12,289,892 13,361,443 11,641,893

CONSOLIDATED CONDENSED BALANCE SHEETS

(thousands except share data)

March 31, March 31,

2008 2007

ASSETS

Current assets:

Cash and cash equivalents $79,258 $9,106

Restricted cash 1,123 1,590

Trade accounts receivable, less allowance

for doubtful accounts of $3,940

and $2,827, respectively

Product sales receivables 12,098 13,133

Patient service receivables 9,085 6,104

Inventories 9,796 7,835

Deferred income taxes 1,656 2,463

Other current assets 3,294 3,153

Total current assets 116,310 43,384

Property and equipment, net 18,428 18,482

Long-term deferred income taxes 0 607

Other assets 1,241 434

Total assets $135,979 $62,907

LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:

Accounts payable $11,097 $12,546

Accrued expenses 14,241 10,331

Short-term portion of capitalized leases 36 36

Short-term debt and vendor financing 82 2,710

Income taxes payable 349 629

Total current liabilities 25,805 26,252

Long-term deferred tax liability 208 0

Long-term portion of capitalized leases 22 58

Long-term debt and vendor financing 22,556 8,679

Total liabilities 48,591 34,989

Commitments and contingencies

Stockholders' equity:

Preferred stock, $.01 par value, 500,000

shares authorized, none issued 0 0

Common stock, $.01 par value, 28,200,000

shares authorized, including

3,200,000 designated Class B:

Common stock - 13,074,593 and 9,498,518 shares

issued and outstanding at March 31, 2008 and

March 31, 2007, respectively 131 95

Class B stock - 1,162,500 shares issued and

outstanding at March 31, 2008 and March 31,

2007, respectively 12 12

Additional paid in capital 92,586 38,911

Accumulated other comprehensive income 2,210 106

Accumulated deficit (7,551) (11,206)

Total stockholders' equity 87,388 27,918

Total liabilities and stockholders' equity $135,979 $62,907

SEGMENT INFORMATION

The Company operates in two businesses: Healthcare Services and Medical Products. The Company evaluates performance and allocates resources based on profit or loss from operations before income taxes, not including foreign exchange gains or losses. The following segment information has been provided per Statement of Financial Accounting Standards No. 131, "Disclosures about Segments of an Enterprise and Related Information:"

Healthcare Medical

Services Products Total

As of March 31, 2008:

Assets $93,727,000 $42,252,000 $135,979,000

For the three months ended March

31, 2008:

Sales and service revenue $17,462,000 $17,162,000 $34,624,000

Gross Profit n/a* 3,896,000 n/a

Gross Profit % n/a* 23% n/a

Income (loss) from continuing

operations before foreign

exchange $2,285,000 $(1,604,000) $681,000

Foreign exchange loss (255,000)

Income from continuing operations $426,000

Other (expense), net (2,398,000)

(Loss) from continuing operations

before income taxes $(1,972,000)

Healthcare Medical

Services Products Total

As of March 31, 2007:

Assets $34,129,000 $28,778,000 $62,907,000

For the three months ended March

31, 2007:

Sales and service revenue $12,821,000 $11,861,000 $24,682,000

Gross Profit n/a* 2,919,000 n/a*

Gross Profit % n/a* 25% n/a*

Income (loss) from continuing

operations before foreign

exchange $1,623,000 $(1,258,000) $365,000

Foreign exchange gain 574,000

Income from continuing operations $939,000

Other(expense), net (72,000)

Income from continuing operations

before income taxes $867,000

Healthcare Medical

Services Products Total

As of March 31, 2008:

Assets $93,727,000 $42,252,000 $135,979,000

For the twelve months ended March

31, 2008:

Sales and service revenue $65,817,000 $64,241,000 $130,058,000

Gross Profit n/a* 16,562,000 n/a

Gross Profit % n/a* 26% n/a

Income (loss) from continuing

operations before foreign

exchange
'/>"/>

SOURCE Chindex International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Chindex International Announces Shelf Registration, Related Strategy and Guidance
2. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Fourth Quarter and Year End Results on Thursday, June 12, 2008
3. Chindex International Announces Conference Call to Discuss Its Fiscal 2008 Third Quarter Results on Friday, February 8, 2008
4. Chindex International, Inc. to Present at 2008 UBS Global Healthcare Services Conference
5. Chindexs United Family Hospitals and Clinics and NBC Enter into Healthcare Services Agreement
6. JPMorgans Principal Investment Management Group to Invest in Chindex International, Inc.
7. LifeStem International, Inc. Announces Increased Revenues, Decreased Operating Expenses
8. MINRAD International, Inc. to Discuss 2008 First Quarter Financial Results on Tuesday, May 13, 2008
9. MINRAD International, Inc. Announces $40.0 Million Private Placement
10. China Yingxia International, Inc. Acquires Grocery Chain and Online Distribution Network
11. Cryo-Cell International, Inc. Reports First Quarter 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... , May 3, 2016  Dr. Thomas P. ... in The Woodlands, Texas , now ... percent of treated fat cells in just 25-minutes, leaving ... to 90 percent of Americans report feeling bothered by ... fat reduction procedures are a growing industry. This innovative ...
(Date:5/3/2016)... ... 03, 2016 , ... Nashville Fertility Center has joined a ... reproductive endocrinologists, including Dr. George Hill at Nashville Fertility Center, created ... build families. , Ovation Fertility is a nationwide network of leading fertility centers ...
(Date:5/2/2016)... Willoughby, Ohio (PRWEB) , ... May 02, 2016 ... ... website. Designed with its clients in mind, the fresh look and added functionality ... capabilities. , “Recent years have seen a dynamic shift in agriculture – from ...
(Date:5/2/2016)... PA (PRWEB) , ... May 02, 2016 , ... ... proud to report on the pre-launch success of their revolutionary, veterinarian-designed product for ... cats to stalk, trap, and play with their food the way nature intended. ...
Breaking Biology Technology:
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
(Date:3/22/2016)... and SANDY, Utah , ... which operates the highest sample volume laboratory in ... Genomics and UNIConnect, leaders in clinical sequencing informatics and ... launch of a project to establish the informatics infrastructure ... NSO has been contracted by the Ontario ...
Breaking Biology News(10 mins):